QUOTE AND NEWS
Benzinga  Aug 12  Comment 
Pernix Therapeutics Holdings Inc (NASDAQ: PTX) reported its 2Q revenue short of expectations. Brean Capitals’ Difei Yang downgraded the rating on the company from Buy to Hold, expressing concern regarding the unclear path to sustainable revenue...
Benzinga  May 11  Comment 
Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical firm, appointed its Director, John Sedor, as its Chairman and interim CEO. The move followed after its current Chairman, Doug Drysdale, agreeing to step down from the...
Benzinga  May 2  Comment 
Shares of Pernix Therapeutics Holdings Inc (NASDAQ: PTX), a nano-cap specialty pharmaceutical company that focuses on products that addresses unmet medical needs, soared higher by more than 75 percent early Monday morning. Investors and...
Forbes  Mar 17  Comment 
In trading on Thursday, drugs shares were relative laggards, down on the day by about 2.4%. Helping drag down the group were shares of Argos Therapeutics (ARGS), down about 23.8% and shares of Pernix Therapeutics Holdings (PTX) down about 16.5% on...
Benzinga  Feb 9  Comment 
Pernix Therapeutics Holdings Inc (NASDAQ: PTX) shares have dipped 74.85 percent over the past one year, almost down to their 52-week low on February 5, at $1.99. Brean Capital’s Difei Yang has maintained a Buy rating on the company, while...
TheStreet.com  Aug 7  Comment 
NEW YORK (TheStreet) -- Shares of Pernix Therapeutics Holdings were falling 12.41% to $4.80 on heavy trading volume after the pharmaceutical company missed analysts' estimates for earnings in the second quarter. Pernix Therapeutics reported a...





 



References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki